Perinatal SARS-CoV-2 Infection and Neonatal COVID-19: A 2021 Update.
Adult
COVID-19
/ prevention & control
COVID-19 Vaccines
/ administration & dosage
Female
Humans
Infant, Newborn
Infant, Newborn, Diseases
/ prevention & control
Infectious Disease Transmission, Vertical
/ prevention & control
Pregnancy
Pregnancy Complications, Infectious
/ drug therapy
Systemic Inflammatory Response Syndrome
/ drug therapy
COVID-19 Drug Treatment
Journal
NeoReviews
ISSN: 1526-9906
Titre abrégé: Neoreviews
Pays: United States
ID NLM: 101085360
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
entrez:
1
5
2021
pubmed:
2
5
2021
medline:
12
5
2021
Statut:
ppublish
Résumé
The coronavirus disease 2019 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has swept across the world like an indiscriminating wildfire. Pregnant women and neonates are particularly vulnerable to this infection compared with older children and healthy young adults, with unique challenges in their management. Unfamiliarity with the consequences of this novel virus and lack of high-quality data led to considerable heterogeneity in obstetrical and neonatal management early in the pandemic. The aim of the this review is to summarize the impact of SARS-CoV-2 infection on pregnancy and childbirth and to examine care and possible outcomes for neonates with Covid-19-positive mothers. A brief review of vaccines currently approved by the United States Food and Drug Administration for emergency use and their potential effects on pregnant and lactating women in included.
Identifiants
pubmed: 33931474
pii: 22/5/e284
doi: 10.1542/neo.22-5-e1001
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e284-e295Informations de copyright
Copyright © 2021 by the American Academy of Pediatrics.